| Surjo, David (CRS 201307 SVP Business Development + Corproate Administration before Pharm PlanNet GmbH) |
Business Development Manager / Strategy Manager |
CRS Clinical Research Services (Group) |
Germany |
| Surya, Arjun (Curadev 202003 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Curadev (Group) |
India |
| Susemihl, Kai (Fairtec GmbH 201503 Managing Director + Co-founder) |
Managing Director |
Fairtec Kommunikationstechnik GmbH |
Germany |
| Susen, Kathrin (BioPartners Cologne 200505) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Suter, Johannes (Helvetica Capital 202101 CEO) |
Chief Executive Officer (CEO) |
Helvetica Capital (CH) |
Switzerland |
| Suter, Marc J.-F. (Eawag 201103 + President SGMS) |
President/Director/Head Business Group/Unit/Division |
Eawag (Wasserforschungsinstitut des ETH-Bereichs) |
Switzerland |
| Suter-Dick, Laura (Roche 200612 Section Head for New Technologies in Safety) |
n. a. |
Roche (Group) |
Switzerland |
| Sutton, Gary (Flagship Pioneering 202007– SVP Corp Development of Pioneering Medicines before NIBR) |
Business Development Manager / Strategy Manager |
Flagship Pioneering |
United States (USA) |
| Svahn, Matthias (NextCell Pharma AB 201912 CEO + Co-Founder before Karolinska Institutet + Roche) |
Chief Executive Officer (CEO) |
NextCell Pharma AB |
Sweden |
| Svatoš, Aleš (Max Planck 200906 Head of Mass Spectrometry Group at MPI for Chemical Ecology) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Swallow, Mark (Huntsworth 201101 Citigate Dewe Rogerson London Senior Director Life Sciences) |
Public Relations Manager / Investor Relations Manager |
Huntsworth (Group) |
United Kingdom (GB) |
| Swanberg, Greg (BioStorage 201308 CEO) |
Chief Executive Officer (CEO) |
BioStorage (Group) |
United States (USA) |
| Swanepoel, Lisa (Bruker 201008 Bruker South Africa + SAAMS) |
n. a. |
|
South Africa |
| Sweeney, John (Millipore 200908– promoted VP Life Science Business Unit joined 2003 as Director Strategy + Corp Dev) |
n. a. |
Merck (DE) (Group) |
United States (USA) |
| Sweet, Andrew (Scienion 202006 Managing Director of Scienion UK Ltd) |
Managing Director |
Cellink (Group) |
United Kingdom (GB) |
| Swieton, Gernot (Ansyco 200801– Managing Director before Prokurist) |
Managing Director |
Ansyco Analytische Systeme und Componenten GmbH |
Germany |
| Swindells, Mark (Exscientia 201901 COO) |
Chief Operating Officer (COO) |
Exscientia (Group) |
United Kingdom (GB) |
| Sydow, Sabine (VFA 201905 Head of VFA Bio) |
n. a. |
VFA (Verband Forschender Arzneimittelhersteller e. V.) |
Germany |
| Sykes, Richard (Glaxo-Wellcome) |
Chief Executive Officer (CEO) |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Symonds, Jonathan (Novartis 200909–201304 STEPPED DOWN 4/13 before Goldman Sachs + AstraZeneca CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Szebries, Ruth (Stilla Technologies 201910– General Manager + VP Commercial Americas before Qiagen + BGI + Exiqon) |
General Manager (management) |
Stilla Technologies (Group) |
United States (USA) |
| Szillat, Peter (Olympus 200709– Product Manager Immunochemistry) |
n. a. |
Olympus (Group) |
Germany |
| Szolar, Oliver (a:head bio 201908– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
red-stars.com data AG |
Austria |
| Szolar, Oliver (Savira Pharmaceuticals 201210 CEO before Onepharm) |
Chief Executive Officer (CEO) |
Savira Pharmaceuticals GmbH |
Austria |
| Szucs, Thomas (BB Biotech 200505) |
n. a. |
Bellevue (Group) |
Switzerland |
| Szulczewski, Mike (Bruker Corp 201407 President Fluorescence Microscopy business before Prairie Technologies Founder) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Sälzle, Martina (Rentschler 201812 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
| Söhngen, Mariola (Proteome Sciences 202009– CEO before Convert Pharmaceuticals + Mologen + Paion) |
Chief Executive Officer (CEO) |
Proteome Sciences (Group) |
United Kingdom (GB) |
| Söhngen, Wolfgang (Paion 200603 CEO) |
Chief Executive Officer (CEO) |
Paion (Group) |
Germany |
| Söller, Rainer (Anchor Diagnostics GmbH 201508– Managing Director) |
Managing Director |
Anchor Diagnostics GmbH |
Germany |
| Sönnichsen, Birte (Cenix BioScience 200902 COO) |
Chief Operating Officer (COO) |
Cenix BioScience (Group) |
Germany |
| Söyler, Alper (Onkogen Diagnostik 201202 General Manager) |
General Manager (management) |
Onkogen Diagnostik Sistemler Ltd. Sti. |
Turkey |
| Søderberg, Sebastian (Novo Group 201609 VP New Business Developm + Incubation + Acquisitions at Novozymes) |
Business Development Manager / Strategy Manager |
Novo Group (Group) |
Denmark |
| Sørensen, Nikolaj (Orexo 201810 CEO joined 201110 as CCO before Pfizer AB + Boston Consulting Group) |
Chief Executive Officer (CEO) |
Orexo (Group) |
Sweden |
| Taapken, Thomas (InflaRx 202010– CFO before Imcyse + Medigene + Epigenomics + Biotie/elbion + DVC + Burrill) |
Chief Executive Officer (CEO) |
InflaRx (Group) |
Netherlands |
| Taarnhøj, Frederik (FaunaPhotonics 201612 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
FaunaPhotonics ApS |
Denmark |
| Tabernero, Josep (Vall d’Hebron Institute of Oncology 201506 Director) |
President/Director/Head of Research Organisation/Unit |
Vall d’Hebron Institute of Oncology (VHIO) |
Spain (España) |
| Tablak, Steve (GeneWeave 201508 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Tada, Yoshiharu (Analytik Jena 2007–201312 Managing Director of AJ Japan RETIRED 12/13) |
Managing Director |
Endress+Hauser (Group) |
Japan |
| Taguchi, Ryo (Univ Tokyo 201307 Professor) |
Professor |
University of Tokyo |
Japan |
| Taha, Farid (Almirall 201107 Managing Director Germany + Austria + Switzerland) |
Managing Director |
Almirall (Group) |
Spain (España) |
| Takagi, Eiji (Altair Corp 201112 President of Acobio KK before President of Biacore KK) |
President/Director/Head Business Group/Unit/Division |
Altair (Group) |
Japan |
| Takahashi, Jun (Univ Kyoto 202001 at CiRA) |
Researcher (university / research institute) |
University of Kyoto (Kyoto University) |
Japan |
| Takimoto, Chris (Forty Seven 201801 CMO) |
Chief Medical Officer (CMO) |
Forty Seven Inc. |
United States (USA) |
| Takke, Christina (V-Bio Ventures 201511 Managing Partner + Co-Founder before Forbion Capital Partners) |
Partner (venture partner) |
V-Bio Ventures |
Belgium |
| Talbot, Michael (Peak Scientific 201304 Territory Manager Germany) |
Sales Manager / Marketing Manager |
Peak Scientific (Group) |
Germany |
| Tallett, Elizabeth E. (Hunter Partners 201103 Principal before Transcell Technologies CEO + Centocor President) |
Consultant (economic/technology) |
Hunter Partners LLC |
United States (USA) |
| Tamayo, Irene (Lunaphore 201808 Corporate Communications) |
public relations / investor relations |
Lunaphore Technologies S.A. |
Switzerland |
| Tamborini, Monica L. (Biofrontera 2015Q1– CEO of newly established US subsidiary) |
Chief Executive Officer (CEO) |
Biofrontera (Group) |
United States (USA) |
| Tamir, Ronen (Rosetta Genomics 200712– Exec VP Marketing + Communication before Novartis VP Investor Relations NA) |
Sales Manager / Marketing Manager |
Rosetta Genomics (Group) |
Israel |
| Tamminen, Manu (Genomill Health 201912 CTO) |
Chief Technology/Technical Officer (CTO) |
Genomill Health (FI) |
Finland |
| Tan, Ben T.G. (ObsEva 201409– VP Commercial + BusDev before Evolva + Novartis/Speedel + Organon + Roche) |
Business Development Manager / Strategy Manager |
ObsEva (Group) |
Switzerland |
| Tan, Choon Shian (Singapore (govt) 201104 Deputy Managing Director EDB) |
Managing Director |
Singapore (govt) |
Singapore |
| Tanaka, Hiroaki (Debiopharm 201305 Director of Personalized Medicine) |
Research & Development Manager |
Debiopharm (Group) |
Switzerland |
| Tanaka, Satoshi (Actelion 201204 President of Actelion Japan + South Korea) |
President/Director/Head Business Group/Unit/Division |
Johnson & Johnson (JnJ) (Group) |
Japan |
| Tang, Lili (Schauenburg 201709– General Manager at Markes Instruments (Shanghai) Co Ltd) |
General Manager (management) |
Schauenburg (Group) |
China |
| Tangermann, Pierre (PerioTrap Pharmaceuticals 201901– Managing Director) |
Managing Director |
PerioTrap Pharmaceuticals GmbH |
Germany |
| Tannenbaum, Renee P. (Nordic Nanovector 201605– Board Member before AbbVie + Èlan + Novartis + BMS) |
Board member |
Nordic Nanovector (Group) |
Norway |
| Tanner, Chris (Cassiopea 201507 CFO + Head of Investor Relations + Cosmo Pharmaceuticals CFO + Head IR before UBS) |
Chief Financial Officer (CFO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
| Tardif, Paul (Waters 201806 Senior Director Corp Development) |
Business Development Manager / Strategy Manager |
Waters (Group) |
United States (USA) |
| Tarlach, Stephan (bmp 200503) |
n. a. |
bmp (Group) |
Germany |
| Tarr, Ian J. (Current BioData 200610– CEO before Thomson Scientific before Current Drugs Ltd) |
Chief Executive Officer (CEO) |
Science Navigation Group |
Switzerland |
| Tasaka, Masao (NAIST 2010 Professor within Plant Science Global Top Education Program) |
Professor |
Nara Institute of Science and Technology (NAIST) |
Japan |
| Tascione, Roberto (Zambon 201907 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
| Tasker, Tim (Heptares 201401– CMO before own consulting firm before Evotec + GSK) |
Chief Medical Officer (CMO) |
Evotec (Group) |
Germany |
| Tauber, Erich (Themis Bioscience GmbH 201505 CEO) |
Chief Executive Officer (CEO) |
Merck (US) (MSD) (Group) |
Austria |
| Tavares, Maria da Graça (Eric Salmon & Partners 201410) |
Human Resources Manager |
Eric Salmon & Partners (Group) |
Germany |
| Taylor, Anthony (Tofwerk AG 201503 Business Development Manager before Thermo Fisher) |
Business Development Manager / Strategy Manager |
TOFwerk AG |
Switzerland |
| Taylor, Ian (Solentim 201901 Commercial Director before CN Bio Innvoations + Oxtex Ltd + SAW Instruments) |
Sales Manager / Marketing Manager |
Solentim (Group) |
United Kingdom (GB) |
| Taylor, Michael D. (Ensemble Discovery 200811 CEO) |
Chief Executive Officer (CEO) |
Ensemble Therapeutics |
United States (USA) |
| Tchelingerian, John (Promethera 201509– CEO before Silver Ocean Ventures + Neurotech + Diatos) |
Chief Executive Officer (CEO) |
Promethera (Group) |
Belgium |
| Tebbe, Andreas (Kinaxo 200708– Head Mass Spectrometry before post doc scientist at Roche Research Centre) |
Head Mass Spectrometry / NMR Laboratory (industry) |
Evotec (Group) |
Germany |
| Teburi, Kevin (Genedata 201702– Managing Director of Genedata Ltd) |
Managing Director |
Genedata (Group) |
United Kingdom (GB) |
| Tedder, Richard (Qiagen 200702) |
n. a. |
Qiagen (Group) |
Germany |
| Tediosi, Riccardo (Bruker 201606 Manager of Bruker BioSpin Superconducting Technologies group) |
n. a. |
Bruker (Group) |
Switzerland |
| Teetz, Wolfram (eADMET GmbH 201109 Managing Director) |
Managing Director |
eADMET GmbH |
Germany |
| Tegtmeyer, Axel (Thermolinear 201006 Managing Director + Co-owner) |
Managing Director |
Thermolinear Isotopenmassenspektrometer GmbH |
Germany |
| Tehrani, Ali (Zymeworks 201510 CEO) |
Chief Executive Officer (CEO) |
Zymeworks (Group) |
Canada |
| Teichmann, Raphael (Monipol 1995–201108– Managing Director + co-founder) |
Managing Director |
Monipol (Group) |
Poland |
| Teifel, Michael (Æterna Zentaris 201308 VP Preclinical Developm at Æterna Zentaris GmbH) |
Research & Development Manager |
Æterna Zentaris (Group) |
Germany |
| Tekçe, Ercan (JSB Deutschland GmbH 201507 Sales Specialist) |
Sales Manager / Marketing Manager |
Joint Analytical Systems (JSB) (Group) |
Germany |
| Tempelmaier, Brigitte (LISAvienna 201405 Project Manager Marketing + PR) |
Public Relations Manager / Investor Relations Manager |
Austria (govt) |
Austria |
| Tenzer, Stefan (Univ Mainz 201312 Prof at Institute for Immunology at Univ Medical Center) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
| Teodoro, Miguel (Boehringer Ingelheim 201502 Head of IT Research) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Tepel, Clemens M. (DeepSpin GmbH 202010 Managing Director (CEO) + Co-Founder) |
Managing Director |
DeepSpin GmbH |
Germany |
| Terhart, Peter (S-Refit 200503) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Terhorst, Rüdiger G. (Parter Capital 201411) |
n. a. |
Parter Capital Group AG |
Switzerland |
| Termeer, Henri A. (Genzyme 1985–201106 CEO joined Genzyme 1983) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
United States (USA) |
| Ternes, Frank (Northway 201810– CBO at Biotechpharma UAB before Rentschler + Boehringer Ingelheim) |
Chief Business Officer (CBO) |
Northway (Group) |
Lithuania |
| Terpe, Kay (SensoQuest 200809) |
n. a. |
SensoQuest GmbH |
Germany |
| Terrett, Jon (CRISPR Therapeutics 201706 Head of Immuno-Oncology Research + Translation) |
Research & Development Manager |
CRISPR Therapeutics (Group) |
Switzerland |
| Terzenbach, Detlef (Frankfurt BioTech Alliance 200705) |
n. a. |
Frankfurt BioTech Alliance e. V. |
Germany |
| Tetko, Igor (eADMET GmbH 201109 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
eADMET GmbH |
Germany |
| Thakur, Rohan A. (Bruker 201101 Bruker Daltonics before PharmaNet before Taylor Technology before Thermo Fisher) |
General Manager (management) |
Bruker (Group) |
United States (USA) |
| Thamer, Helmut (TuTech Innovation GmbH 200705) |
n. a. |
Technical University Hamburg-Harburg (TUHH) |
Germany |
| Tharaud, Cécile (INSERM 201403– CEO of Inserm Transfert Initiative before CEO of Inserm Transfert) |
Chief Executive Officer (CEO) |
France (govt) |
France |
| Thelen, Tobias (Altmann Analytik 201312 Managing Director) |
Managing Director |
Altmann Analytik (Group) |
Germany |
| Theodoropulos, Constantine (GO Therapeutics 201709 CEO) |
Chief Executive Officer (CEO) |
GO Therapeutics Inc. |
United States (USA) |
| Theoharis, Stefanos (Bone Therapeutics 202003– CBO before Cell Medica + Apceth + Antisense Pharma + Roche + Lazard) |
Chief Business Officer (CBO) |
Bone Therapeutics (Group) |
Belgium |
| Therianos, Stavros (Diagnoplex 201306 CEO) |
Chief Executive Officer (CEO) |
Diagnoplex S.à.r.l. |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 64 65 66 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
